Advertisement
Screener

TELA Bio, Inc. (TELA) Deferred Tax Liabilities, Gross

2.5 / 5 stars · 33/66 Roast Me

TELA Bio, Inc. Deferred Tax Liabilities, Gross

TELA Bio, Inc. (TELA) had Deferred Tax Liabilities, Gross of $609.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-25.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-25

  • 2025-12-31: Deferred Tax Liabilities, Gross $609.00K.
  • 2024-12-31: Deferred Tax Liabilities, Gross $756.00K.
  • 2023-12-31: Deferred Tax Liabilities, Gross $920.00K.
  • 2022-12-31: Deferred Tax Liabilities, Gross $737.00K.
Period endDeferred Tax Liabilities, Gross
2025-12-31$609.00K
10-K · filed 2026-03-25
2024-12-31$756.00K
10-K · filed 2026-03-25
2023-12-31$920.00K
10-K · filed 2025-03-21
2022-12-31$737.00K
10-K · filed 2024-03-22
2021-12-31$89.00K
10-K · filed 2023-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
InspireMD, Inc. (NSPR)$0.033B